Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-26 @ 5:44 AM
Study NCT ID:
NCT04762160
Status:
TERMINATED
Last Update Posted:
2024-03-25
First Post:
2021-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SYMPHONY-2, A Trial to Examine Combination of Tazemetostat With Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma
Sponsor:
Epizyme, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-22
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-05
First Submit QC Date:
None
Study First Post Date:
2021-02-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-31
Results First Submit QC Date:
None
Results First Post Date:
2023-11-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-21
Last Update Post Date:
2024-03-25
Last Update Post Date Type:
ACTUAL